15-DemethylplumierideCAS# 132586-69-7 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 132586-69-7 | SDF | Download SDF |
PubChem ID | 44593505 | Appearance | Powder |
Formula | C20H24O12 | M.Wt | 456.4 |
Type of Compound | Iridoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (1S,4aS,7R,7aS)-4'-[(1S)-1-hydroxyethyl]-5'-oxo-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[4a,7a-dihydro-1H-cyclopenta[c]pyran-7,2'-furan]-4-carboxylic acid | ||
SMILES | CC(C1=CC2(C=CC3C2C(OC=C3C(=O)O)OC4C(C(C(C(O4)CO)O)O)O)OC1=O)O | ||
Standard InChIKey | GGLAWDIODKKBQZ-SZSWQRSVSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. 15-Demethylplumieride is a quality control index of Plumeriarubra L. |
15-Demethylplumieride Dilution Calculator
15-Demethylplumieride Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.1911 mL | 10.9553 mL | 21.9106 mL | 43.8212 mL | 54.7765 mL |
5 mM | 0.4382 mL | 2.1911 mL | 4.3821 mL | 8.7642 mL | 10.9553 mL |
10 mM | 0.2191 mL | 1.0955 mL | 2.1911 mL | 4.3821 mL | 5.4777 mL |
50 mM | 0.0438 mL | 0.2191 mL | 0.4382 mL | 0.8764 mL | 1.0955 mL |
100 mM | 0.0219 mL | 0.1096 mL | 0.2191 mL | 0.4382 mL | 0.5478 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Olanzapine
Catalog No.:BCC5042
CAS No.:132539-06-1
- (Z)-Pugnac
Catalog No.:BCC5333
CAS No.:132489-69-1
- 2-TEDC
Catalog No.:BCC6735
CAS No.:132465-10-2
- Alosetron-d3 Hydrochloride
Catalog No.:BCC1345
CAS No.:1189919-71-8
- Neohesperidin
Catalog No.:BCN5915
CAS No.:13241-33-3
- Neoeriocitrin
Catalog No.:BCN3271
CAS No.:13241-32-2
- Chrysophanol 8-O-glucoside
Catalog No.:BCN6175
CAS No.:13241-28-6
- β-D-Glucopyranoside,(3β,6α,16β,20R,24S)-3-[(3,4-di-O-acetyl-β-D-xylopyranosyl)oxy]-20, 24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl
Catalog No.:BCC8370
CAS No.:1324005-51-7
- TC-G 1006
Catalog No.:BCC6277
CAS No.:1324003-64-6
- Boc-Gln(Trt)-OH
Catalog No.:BCC3384
CAS No.:132388-69-3
- Boc-Asn(Trt)-OH
Catalog No.:BCC3360
CAS No.:132388-68-2
- Fmoc-Gln(Trt)-OPfp
Catalog No.:BCC3486
CAS No.:132388-65-9
- Bruceanic acid C
Catalog No.:BCN7999
CAS No.:132587-60-1
- CCMQ
Catalog No.:BCC6984
CAS No.:132623-44-0
- Otophylloside O
Catalog No.:BCN7337
CAS No.:1326583-08-7
- Senecionine N-oxide
Catalog No.:BCN2130
CAS No.:13268-67-2
- Fmoc-Tle-OH
Catalog No.:BCC2657
CAS No.:132684-60-7
- [Leu31,Pro34]-Neuropeptide Y (human, rat)
Catalog No.:BCC5722
CAS No.:132699-73-1
- PyBrOP
Catalog No.:BCC2821
CAS No.:132705-51-2
- CP 96345
Catalog No.:BCC7509
CAS No.:132746-60-2
- Blonanserin
Catalog No.:BCC3740
CAS No.:132810-10-7
- YS-49
Catalog No.:BCC2067
CAS No.:132836-42-1
- Terchebulin
Catalog No.:BCN3264
CAS No.:132854-40-1
- PD 81723
Catalog No.:BCC7032
CAS No.:132861-87-1
Cytotoxic constituents of the bark of Plumeria rubra collected in Indonesia.[Pubmed:1965200]
J Nat Prod. 1990 Nov-Dec;53(6):1447-55.
By bioactivity-directed fractionation, six cytotoxic constituents have been characterized from the bark of Plumeria rubra collected in Indonesia. Three iridoids, fulvoplumierin [1], allamcin [2], and allamandin [3], as well as 2,5-dimethoxy-p-benzoquinone [4], were found to be active constituents of the P. rubra petroleum-ether- and CHCl3-soluble extracts. Cytotoxic compounds isolated from the H2O-soluble extract of the bark were the iridoid plumericin [5], and the lignan liriodendrin [6]. Each of these substances was found to demonstrate general cytotoxic activity when evaluated with a panel of cell lines composed of murine lymphocytic leukemia (P-388) and a number of human cancer cell-types (breast, colon, fibrosarcoma, lung, melanoma, KB). Five additional iridoids, 15-Demethylplumieride [7], plumieride [8], alpha-allamcidin [9], beta-allamcidin [10], and 13-O-trans-p-coumaroylplumieride [11], were obtained as inactive constituents. Compound 7 was found to be a novel natural product, and its structure was determined by spectroscopic methods and by conversion to plumieride [8]. The configuration of the C-4 stereocenter was unambiguously assigned for compounds 9 and 10, and certain nmr reassignments have been provided for compound 1.
Isolation and characterization of secondary metabolites from Plumeria obtusa.[Pubmed:22115036]
J Asian Nat Prod Res. 2011 Dec;13(12):1122-7.
Chromatographic purification of the methanolic extract of Plumeria obtusa yielded two new iridoid obtusadoids A (1) and B (2), along with eight known compounds plumieridin A (3), plumieridine (4), 1alpha-plumieride (5), 15-Demethylplumieride (6), rel-(3R,3'S,4R,4'S)-3,3',4,4'-tetrahydro-6,6'-dimethoxy[3,3'-bi-2H-benzopyran]-4, 4'-diol (7), glochiflavanoside B (8), oleanolic acid (9), and methyl coumarate (10). The structures of all the isolates (1-10) were determined by NMR spectroscopy and mass spectrometry. The data of known compounds (3-10) were further compared with the reported data for these compounds.